These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38813792)

  • 1. Evolution of global polio eradication strategies: targets, vaccines, and supplemental immunization activities (SIAs).
    Thompson KM; Badizadegan K
    Expert Rev Vaccines; 2024; 23(1):597-613. PubMed ID: 38813792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights From Modeling Preventive Supplemental Immunization Activities as a Strategy to Eliminate Wild Poliovirus Transmission in Pakistan and Afghanistan.
    Kalkowska DA; Thompson KM
    Risk Anal; 2021 Feb; 41(2):266-272. PubMed ID: 32144841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strengthening the partnership between routine immunization and the global polio eradication initiative to achieve eradication and assure sustainability.
    Abdelwahab J; Dietz V; Eggers R; Maher C; Olaniran M; Sandhu H; Vandelaer J
    J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S498-503. PubMed ID: 25316872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polio by the Numbers-A Global Perspective.
    Badizadegan K; Kalkowska DA; Thompson KM
    J Infect Dis; 2022 Oct; 226(8):1309-1318. PubMed ID: 35415741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of poliovirus modeling performed from 2000 to 2019 to support global polio eradication.
    Thompson KM; Kalkowska DA
    Expert Rev Vaccines; 2020 Jul; 19(7):661-686. PubMed ID: 32741232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of polio eradication activities on routine immunization: lessons from the 2013 outbreak response in Somali region of Ethiopia.
    Tafesse B; Tekle E; Wondwossen L; Bogale M; Fiona B; Nsubuga P; Tomas K; Kassahun A; Kathleen G; Teka A
    Pan Afr Med J; 2017; 27(Suppl 2):4. PubMed ID: 28983392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress toward poliomyelitis eradication--Nigeria, January 2013-September 2014.
    Etsano A; Gunnala R; Shuaib F; Damisa E; Mkanda P; Banda R; Korir C; Enemaku O; Corkum M; Usman S; Davis LB; Nganda Gw; Burns CC; Mahoney F; Vertefeuille JF;
    MMWR Morb Mortal Wkly Rep; 2014 Nov; 63(46):1059-63. PubMed ID: 25412063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria.
    Duintjer Tebbens RJ; Pallansch MA; Wassilak SG; Cochi SL; Thompson KM
    PLoS One; 2015; 10(6):e0130123. PubMed ID: 26068928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission.
    Thompson KM; Duintjer Tebbens RJ
    BMC Infect Dis; 2015 Sep; 15():376. PubMed ID: 26382234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling and Managing Poliovirus Risks: We are Where we are….
    Thompson KM
    Risk Anal; 2021 Feb; 41(2):223-228. PubMed ID: 33590520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
    Orenstein WA;
    Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Proactive and Reactive Strategies for Polio Eradication Activities in Pakistan and Afghanistan.
    Duintjer Tebbens RJ; Thompson KM
    Risk Anal; 2019 Feb; 39(2):389-401. PubMed ID: 30239026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging challenges to realizing global polio eradication and their solutions.
    M A S
    East Mediterr Health J; 2022 Jul; 28(7):515-520. PubMed ID: 35959667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immediate impact of the COVID-19 pandemic on polio immunization and surveillance activities.
    Burkholder B; Wadood Z; Kassem AM; Ehrhardt D; Zomahoun D
    Vaccine; 2023 Apr; 41 Suppl 1():A2-A11. PubMed ID: 34756614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress Toward Polio Eradication - Worldwide, January 2017-March 2019.
    Greene SA; Ahmed J; Datta SD; Burns CC; Quddus A; Vertefeuille JF; Wassilak SGF
    MMWR Morb Mortal Wkly Rep; 2019 May; 68(20):458-462. PubMed ID: 31120868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expected Implications of Globally Coordinated Cessation of Serotype 3 Oral Poliovirus Vaccine (OPV) Before Serotype 1 OPV.
    Kalkowska DA; Thompson KM
    Risk Anal; 2021 Feb; 41(2):312-319. PubMed ID: 32936466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of Global Polio Eradication Initiative-Funded Personnel to the Strengthening of Routine Immunization Programs in the 10 Focus Countries of the Polio Eradication and Endgame Strategic Plan.
    van den Ent MMVX; Swift RD; Anaokar S; Hegg LA; Eggers R; Cochi SL
    J Infect Dis; 2017 Jul; 216(suppl_1):S244-S249. PubMed ID: 28838165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breaking the Last Chains of Poliovirus Transmission: Progress and Challenges in Global Polio Eradication.
    Kew O; Pallansch M
    Annu Rev Virol; 2018 Sep; 5(1):427-451. PubMed ID: 30001183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health economic analysis of vaccine options for the polio eradication endgame: 2022-2036.
    Thompson KM; Kalkowska DA; Badizadegan K
    Expert Rev Vaccines; 2022 Nov; 21(11):1667-1674. PubMed ID: 36154436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral polio vaccine stockpile modeling: insights from recent experience.
    Thompson KM; Kalkowska DA; Badizadegan K
    Expert Rev Vaccines; 2023; 22(1):813-825. PubMed ID: 37747090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.